Understand the source comparison
Quickcomparison
Dose Range Defensin (HBD-3) 1–50 μg/mL (research) LL-37 0.5–1.6 mg/mL (topical) Frequency As needed Once daily Administration Topical application (research/wound care) Topical application (wound healing) Cycle Length Ongoing/indefinite 12+ weeks Onset Speed Ra
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Dose Range
- Defensin (HBD-3)
- 1–50 μg/mL (research)
- LL-37
- 0.5–1.6 mg/mL (topical)
- Frequency
- As needed
- Once daily
- Administration
- Topical application (research/wound care)
- Topical application (wound healing)
- Cycle Length
- Ongoing/indefinite
- 12+ weeks
- Onset Speed
- Rapid (hours to days)
- Moderate (1-2 weeks)
- Evidence Level
- Moderate human trials (Phase 1-2)
- Efficacy